CSIMarket
 
Pfizer Inc  (PFE)
Other Ticker:  
 
 

Pfizer Inc Income Statement Quarterly

PFE


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

(Dec 31 2023)
IV. Quarter
(Oct 01 2023)
III. Quarter
(Jul 02 2023)
II. Quarter
(Apr 02 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Revenue From Contract With Customer Excluding Assessed Tax - - -
Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer - - -
Total Revenue 14,248.00 13,232.00 12,734.00 18,282.00 24,289.00
Cost of Goods and Services Sold 7,562.00 9,269.00 3,237.00 4,886.00 9,649.00
Gross Profit 6,686.00 3,963.00 9,497.00 13,396.00 14,640.00
Selling, Administration, Marketing 4,575.00 3,281.00 3,497.00 3,418.00 4,645.00
Depriciation & Amortization 1,267.00 1,179.00 1,184.00 1,103.00 1,130.00
Research & development 2,815.00 2,711.00 2,648.00 2,505.00 3,616.00
Restructuring Charges AndAcquisition Related Costs 2,565.00 155.00 214.00 9.00 795.00
Other exp. /-income - - - - -
Special Items - - - - -
Total operating costs including COS 18,784.00 16,595.00 10,780.00 11,921.00 19,835.00
Operating income/-loss -4,536.00 -3,363.00 1,954.00 6,361.00 4,454.00
Other Deductions / - Income
Interest expense - - - - -
Interest income - - - - -
Net interest expense/-income - - - - -
Loss/ -Gain on Investment - - - - -
Income from affiliates - - - - -
Minority interest - - - - -
Financing Loss/ -Income - - - - -
Other loss/ -income -407.00 -11.00 -315.00 91.00 -777.00
Total costs & expenses 18,377.00 16,584.00 10,465.00 12,012.00 19,058.00
Income /-loss before income taxes -4,129.00 -3,352.00 2,269.00 6,270.00 5,231.00
Income taxes expenses/-benefit -795.00 -964.00 -71.00 715.00 230.00
Income after income taxes -3,335.00 -2,388.00 2,340.00 5,555.00 5,000.00
Net income/-loss of other equity - - - - -
Income/-loss from cont. Ops. -3,334.00 -2,388.00 2,340.00 5,555.00 5,001.00
Accounting change - - - - -
Discontinued operations -26.00 12.00 -2.00 1.00 2.00
Extraordinary items - - - - -
Net Income/-loss -3,360.00 -2,376.00 2,338.00 5,556.00 5,003.00
Noncontrolling interests 9.00 6.00 11.00 13.00 8.00
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder -3,369.00 -2,382.00 2,327.00 5,543.00 4,994.00
EBIT -4,129.00 -3,352.00 2,269.00 6,270.00 5,231.00
EBITD -2,459.00 -1,792.00 3,842.00 7,757.00 6,750.00
EBITDA -2,459.00 -1,792.00 3,842.00 7,757.00 6,750.00


Per Share (GAAP Quarterly, in $) (Dec 31 2023)
IV. Quarter
(Oct 01 2023)
III. Quarter
(Jul 02 2023)
II. Quarter
(Apr 02 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Basic EPS (excl. extra items) -0.59 -0.42 0.41 0.98 0.89
   Extraordinary items 0.01 0.00 0.00 0.00 0.00
Basic Net EPS -0.60 -0.42 0.41 0.98 0.89
Basic shares outstanding (Mill. of Units) 5,646.00 5,646.00 5,646.00 5,634.00 5,615.00
   EPS other shares - - - - -
Diluted Net EPS -0.59 -0.42 0.41 0.97 0.87
Diluted average shares (Mill. of Units) 5,727.03 5,646.00 5,713.00 5,727.00 5,735.28
Dividend per share 0.404 0.41 0.405 0.402 0.391



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com